Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided EPS guidance of $6.44-6.74 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.54. Walgreens Boots Alliance also updated its FY19 guidance to $6.40-6.70 EPS.
Shares of NASDAQ WBA opened at $67.26 on Friday. The company has a market capitalization of $65.84 billion, a price-to-earnings ratio of 11.23, a PEG ratio of 1.08 and a beta of 0.76. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.38 and a current ratio of 0.80. Walgreens Boots Alliance has a 52-week low of $59.07 and a 52-week high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.43 by $0.03. The company had revenue of $33.79 billion for the quarter, compared to analyst estimates of $33.90 billion. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The firm’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.28 earnings per share. Analysts predict that Walgreens Boots Alliance will post 6.53 earnings per share for the current fiscal year.
A number of analysts have issued reports on WBA shares. TheStreet raised Walgreens Boots Alliance from a c+ rating to a b rating in a research report on Wednesday, September 12th. Zacks Investment Research raised Walgreens Boots Alliance from a hold rating to a buy rating and set a $81.00 target price on the stock in a research report on Tuesday, September 25th. BidaskClub raised Walgreens Boots Alliance from a hold rating to a buy rating in a research report on Wednesday, September 12th. Loop Capital boosted their target price on Walgreens Boots Alliance from $80.00 to $82.00 and gave the company a buy rating in a research report on Friday, October 12th. Finally, Needham & Company LLC raised Walgreens Boots Alliance to a buy rating and set a $94.00 price objective on the stock in a research report on Thursday. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and seven have assigned a buy rating to the stock. The company currently has an average rating of Hold and a consensus target price of $79.39.
In related news, SVP Kimberly R. Scardino sold 11,970 shares of the business’s stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $79.79, for a total transaction of $955,086.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the business’s stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the transaction, the executive vice president now owns 81,076 shares of the company’s stock, valued at approximately $6,386,356.52. The disclosure for this sale can be found here. Insiders have sold 73,756 shares of company stock worth $5,824,194 in the last ninety days. Corporate insiders own 15.73% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4034752/walgreens-boots-alliance-wba-issues-fy-2019-earnings-guidance.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: What is systematic risk?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.